Results 11 to 20 of about 956,180 (270)

Beta-lactamases in Enterobacteriaceae infections in children [PDF]

open access: yesJournal of Infection, 2016
Multi-drug resistance in Gram negative bacteria, particularly in Enterobacteriaceae, is a major clinical and public health challenge. The main mechanism of resistance in Enterobacteriaceae is linked to the production of beta-lactamase hydrolysing enzymes such as extended spectrum beta-lactamases (ESBL), AmpC beta-lactamases and carbapenemases ...
Moxon, Christopher Alan   +1 more
openaire   +4 more sources

Treating infections caused by carbapenemase-producing Enterobacteriaceae [PDF]

open access: yesClinical Microbiology and Infection, 2014
Carbapenemase-producing Enterobacteriaceae (CPE) have spread worldwide, causing serious infections with increasing frequency. CPE are resistant to almost all available antibiotics, complicating therapy and limiting treatment options. Mortality rates associated with CPE infections are unacceptably high, indicating that the current therapeutic approaches
Tzouvelekis, L.S.   +4 more
openaire   +5 more sources

Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation [PDF]

open access: yesBMC Nephrology, 2019
Backgound In recent years we have witnessed an increase in infections due to multidrug-resistant organisms in kidney transplant recipients (KTR). In our setting, we have observed a dramatic increase in infections caused by extended-spectrum betalactamase-
Gemma Sanclemente   +9 more
doaj   +2 more sources

Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Infektionen durch multiresistente gramnegative Stäbchen – ESBL-Bildner, Carbapenemase-bildende Enterobacteriaceae, Carbapenem-resistente Acinetobacter baumannii

open access: yesGMS Infectious Diseases, 2020
This is the sixteenth chapter of the guideline “Calculated initial parenteral treatment of bacterial infections in adults – update 2018” in the 2 updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been
Grabein, Béatrice   +3 more
doaj   +2 more sources

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae [PDF]

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2017
Objective. To investigate the risk factors underlying the occurrence and mortality of bloodstream infections (BSIs) with carbapenem-resistant Enterobacteriaceae (CRE). Methods.
Xiaopeng Li, Huan Ye
doaj   +2 more sources

Carbapenem Resistant Enterobacteriaceae infections in Houston, Texas: An outline [PDF]

open access: yesOnline J Public Health Inform, 2017
ObjectiveTo examine demographic as well as clinical characteristics of theCarbapenam Resistant Enteriobacteriacae (CRE) Organisms cases inHouston, Texas, 2015-2016IntroductionAccording to CDC, CRE is used to describe bacteria that are non-susceptible to one or more carbapenems; doripenem, meropenemor imipenem and resistant to third generation ...
Rehman, Hafeez   +3 more
europepmc   +3 more sources

Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs. [PDF]

open access: yesJ Clin Microbiol, 2015
ABSTRACT The Clinical and Laboratory Standards Institute (CLSI) lowered the MIC breakpoints for meropenem and imipenem from 4 mg/liter to 1 mg/liter for Enterobacteriaceae in 2010. The breakpoint change improves the probability of pharmacodynamic target attainment and eliminates the need for microbiology ...
Patel TS, Nagel JL.
europepmc   +4 more sources

The Clinical and Molecular Epidemiology of CTX-M-9 Group Producing Enterobacteriaceae Infections in Children [PDF]

open access: yesInfectious Diseases and Therapy, 2019
Robert Bonomo   +2 more
exaly   +2 more sources

Management of carbapenem-resistant Enterobacteriaceae infections [PDF]

open access: yesClinical Microbiology and Infection, 2019
Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly spread worldwide among clinical isolates of Enterobacteriaceae, mostly Klebsiella spp., and is associated with diverse molecular mechanisms. Carbapenem resistance is often associated with resistance
Durante-Mangoni, Emanuele   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy